Differences of Concentration/Dose of Tacrolimus Sustained-Release Capsules in Kidney Transplant Recipients with Different CYP3A5 Genotypes

WANG Shilei; FENG Guiwen

doi:10.3969/j.issn.1004-437X.2021.15.006

Home>Articles>Differences of Concentration/Dose of Tacrolimus Sustained-Release Capsules in Kidney Transplant Recipients with Different CYP3A5 Genotypes

DOI: 10.3969/j.issn.1004-437X.2021.15.006

Differences of Concentration/Dose of Tacrolimus Sustained-Release Capsules in Kidney Transplant Recipients with Different CYP3A5 Genotypes

WANG Shilei

FENG Guiwen

Machine-generated Keywords：

Publication Date：2021-05-25

Online Publishing Date：2026-09-12(First online date of this platform, not the publication date of the document)

Pages：4( 2708-2711 )

Henan Medical Research

ISSN：1004-437X

Year, Vol.(Issue)：2021,30(15)